Harvey Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Harvey Capital Management's HALO Position: Q1 2026 in Review
Harvey Capital Management increased its Halozyme (HALO) stake by 61% in Q1 2026, buying an estimated $2.42M and bringing the position to 90,600 shares worth $5.86M. The position accounts for 1.33% of the portfolio, ranked #20.
Harvey Capital Management first reported a position in HALO in Q3 2013 and has held it in 19 quarters since. The position peaked at $10.6M in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Harvey Capital Management held 90,600 shares of Halozyme worth $5.86M as of Q1 2026.
- Harvey Capital Management bought 34,260 Halozyme shares in Q1 2026, an estimated $2.42M.
- Halozyme made up 1.33% of Harvey Capital Management's portfolio in Q1 2026, its #20 holding.
- Harvey Capital Management first reported a position in Halozyme in Q3 2013 and has held it in 19 quarters since.
- Harvey Capital Management's Halozyme position peaked at $10.6M in Q3 2024.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Harvey Capital Management's 13F filing for Q1 2026, filed 11 May 2026.